Top Core and Group Health Stories
Trump vs. GOP on Medicare drug negotiations
By Jack CraverTrump and the rest of the GOP don't see eye to eye on how to cut Medicare spending.
News, insight, and analysis from industry experts to help benefits brokers, consultants and advisors make their way through the tumultuous reformed health care marketplace. Content will help them grow their practices by focusing on a wide range of products, discussing new sales and marketing strategies and highlighting innovative and disruptive brokers who are forging a new path in today's benefits marketplace.
Trump and the rest of the GOP don't see eye to eye on how to cut Medicare spending.